Skip to main content

Table 3 Multivariable analysis of the factors associated with HCC prevalence in non-cirrhotic NAFLD

From: Hepatocellular carcinoma in nonalcoholic fatty liver disease with or without cirrhosis: a population-based study

 

Noncirrhotic NAFLD

Adjusted ORa

95% CI

P value

Age > 65 years

3.37

2.47–4.59

< 0.001

Male gender

2.57

1.88–3.49

< 0.001

Non-Hispanic white

0.67

0.47–0.97

0.036

Non-Hispanic black

0.74

0.45–1.23

0.245

Hispanic

1.32

0.91–1.91

0.150

Diabetes

1.56

1.15–2.11

0.004

Hypertension

1.24

0.84–1.83

0.278

Hyperlipidemia

0.95

0.66–1.37

0.793

Obese

0.84

0.62–1.13

0.252

Morbid obese

1.06

0.81–1.39

0.658

Smoker

1.75

1.23–2.49

0.002

High ALT

2.69

2.14–3.37

< 0.001

  1. ALT alanine aminotransferases, CI confidence interval, HCC hepatocellular carcinoma, NAFLD non-alcoholic fatty liver disease, OR odds ratio
  2. aFactors adjusted with age, gender and white race